Skip to content

Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04341363
Enrollment
8
Registered
2020-04-10
Start date
2021-04-09
Completion date
2022-05-02
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic Alopecia

Brief summary

The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).

Detailed description

Proposed is an open label trial of tattoo machine microneedling in ten patients with androgenic alopecia. Ten healthy male patients older than 18 years will undergo 6 microneedling sessions. Over the course of six months, subjects will undergo up to six treatment sessions (one session every 30 day). Patients will be evaluated at 8 visits over 8 months with the first visit for screening purposes.

Interventions

DEVICETattoo machine

A SOL Nova Device (brand) tattoo machine will be used to stimulate hair regrowth.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Symmetric hair loss from AGA * Hamilton-Norwood IIIa, III, III vertex, IV, Iva, V with low density hair coverage over majority of alopecic areas * No or minimal scalp hair regrowth on oral and/or topical minoxidil

Exclusion criteria

* Any male with hair loss for other reasons * Unilateral or asymmetric hair loss * Hamilton-Norwood I, II, IIa, Va, IV, VII x * Patients without hair * Patients with the following who would make poor candidates for microneedling such as skin conditions, diabetes, or history of keloid formation * Anything additional existing comorbidities that in the opinion of the investigator may cause unnecessary risk for the patient to participate

Design outcomes

Primary

MeasureTime frameDescription
Total Area Hair Count6 monthsTotal number of hairs in an area of 1 cm\^2

Secondary

MeasureTime frameDescription
SALT Score6 monthsThe Severity of Alopecia Tool measures percentage of scalp hair loss
Hair Shaft Diameter6 monthsThe diameter of the hair shaft as measured by trichoscopy
Number of Follicular Units6 monthsNumber of follicular units with one or more hair follicles over an area of 1cm\^2
Vellus Hairs6 monthsNumber of vellus hairs over an area of 1 cm\^2
Terminal Hairs6 monthsTerminal hairs over an area of 1 cm\^2

Countries

United States

Participant flow

Participants by arm

ArmCount
Microneedling
Participants with androgenic alopecia will receive microneedling with a tattoo machine. Tattoo machine: A SOL Nova Device (brand) tattoo machine will be used to stimulate hair regrowth.
8
Total8

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicMicroneedling
Age, Continuous50.4 years
STANDARD_DEVIATION 15.3
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Hair Shaft Diameters58.0 micrometer
STANDARD_DEVIATION 15.8
Number of hair follicles96.3 hair follicles per cm^2
STANDARD_DEVIATION 37.9
Number of Terminal Hairs87.1 terminal hairs per cm^2
STANDARD_DEVIATION 33.2
Number of Vellus Hairs13.3 vellus hairs per cm^2
STANDARD_DEVIATION 14.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
8 Participants
Region of Enrollment
United States
8 Participants
SALT Score25.0 percentage of hair loss
STANDARD_DEVIATION 20.2
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
6 Participants
Total area hair count100.4 hairs per cm^2
STANDARD_DEVIATION 41.4

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 8
other
Total, other adverse events
1 / 8
serious
Total, serious adverse events
0 / 8

Outcome results

Primary

Total Area Hair Count

Total number of hairs in an area of 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingTotal Area Hair Count126.8 hairs per cm^2Standard Deviation 41.7
Secondary

Hair Shaft Diameter

The diameter of the hair shaft as measured by trichoscopy

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingHair Shaft Diameter54.4 micrometerStandard Deviation 8.1
Secondary

Number of Follicular Units

Number of follicular units with one or more hair follicles over an area of 1cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingNumber of Follicular Units108.8 follicular units per cm^2Standard Deviation 29.7
Secondary

SALT Score

The Severity of Alopecia Tool measures percentage of scalp hair loss

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingSALT Score15.5 percentage of hair lossStandard Deviation 9.7
Secondary

Terminal Hairs

Terminal hairs over an area of 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingTerminal Hairs104.3 terminal hairs per cm^2Standard Deviation 21.9
Secondary

Vellus Hairs

Number of vellus hairs over an area of 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingVellus Hairs18.0 vellus hairs per cm^2Standard Deviation 26.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026